Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Terzah Horton"'
Autor:
Margot Roeten, Suzanne van Dijk, Johan van Meerloo, Zinia Kwidama, Gaya Jenkins, David Teachey, Meenakshi Devidas, Mignon Loh, Gertjan Kaspers, Sonja Zweegman, Gerrit Jansen, Terzah Horton, Jacqueline Cloos
Publikováno v:
HemaSphere, Vol 7, p e81299a0 (2023)
Externí odkaz:
https://doaj.org/article/40d3b42d44514f25bb8ba0bffe07ecbd
Autor:
Sharon M. Castellino, Qinglin Pei, Susan K. Parsons, David Hodgson, Kathleen Mccarten, Terzah Horton, Steve Cho, Yue Wu, Angela Punnett, Hema Dave, Tara O. Henderson, Bradford S. Hoppe, Ann-Marie Charpentier, Frank G. Keller, Kara M. Kelly
Publikováno v:
HemaSphere, Vol 6, Pp 40-40 (2022)
Externí odkaz:
https://doaj.org/article/ffd0c0bb96874a749aa95d35af9fec09
Autor:
Richard Aplenc, Soheil Meshinchi, Lillian Sung, Todd Alonzo, John Choi, Brian Fisher, Robert Gerbing, Betsy Hirsch, Terzah Horton, Samir Kahwash, John Levine, Michael Loken, Lisa Brodersen, Jessica Pollard, Susana Raimondi, Edward Anders Kolb, Alan Gamis
Publikováno v:
Haematologica, Vol 105, Iss 7 (2020)
New therapeutic strategies are needed for pediatric acute myeloid leukemia (AML) to reduce disease recurrence and treatment-related morbidity. The Children’s Oncology Group Phase III AAML1031 trial tested whether the addition of bortezomib to stand
Externí odkaz:
https://doaj.org/article/1923b3bd287f4e0aa61b66541e8b65bc
Autor:
Sharon M. Castellino, Qinglin Pei, Susan K. Parsons, David Hodgson, Kathleen McCarten, Terzah Horton, Steve Cho, Yue Wu, Angela Punnett, Hema Dave, Tara O. Henderson, Bradford S. Hoppe, Anne-Marie Charpentier, Frank G. Keller, Kara M. Kelly
Publikováno v:
N Engl J Med
BACKGROUND: In adults with advanced-stage Hodgkin’s lymphoma, the CD30-directed antibody–drug conjugate brentuximab vedotin combined with multiagent chemotherapy has been shown to have greater efficacy, but also more toxic effects, than chemother
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04c10d044132b7d20e0a4504a5a0ba2a
https://europepmc.org/articles/PMC9945772/
https://europepmc.org/articles/PMC9945772/
Autor:
Trent R, Hummel, Lars, Wagner, Charlotte, Ahern, Maryam, Fouladi, Joel M, Reid, Renee M, McGovern, Matthew M, Ames, Richard J, Gilbertson, Terzah, Horton, Ashish M, Ingle, Brenda, Weigel, Susan M, Blaney
Publikováno v:
Pediatric bloodcancer. 60(9)
We conducted a pediatric phase I study to estimate the maximum tolerated dose (MTD), dose-limiting toxicities (DLT), and pharmacokinetic properties of vorinostat, a histone deacetylase (HDAC) inhibitor, when given in combination with temozolomide in
Autor:
Niewerth, Denise, Kaspers, Gertjan, Jansen, Gerrit, Meerloo, Johan Van, Zweegman, Sonja, Jenkins, Gaye, Whitlock, James, Hunger, Stephen, Xiaomin Lu, Alonzo, Todd, Ven, Peter Van De, Terzah Horton, Cloos, Jacqueline
Individual immunoproteasome subunit protein expression in relapsed childhood acute leukaemia patients. Figure S2. Proteasome subunit mRNA expression in NBM cells. Figure S3. Proteasome subunit catalytic activity in relapsed childhood ALL and AML pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05f0e16f0c0a6153d3cf3080ecef84cb
Autor:
Niewerth, Denise, Kaspers, Gertjan, Jansen, Gerrit, Meerloo, Johan Van, Zweegman, Sonja, Jenkins, Gaye, Whitlock, James, Hunger, Stephen, Xiaomin Lu, Alonzo, Todd, Ven, Peter Van De, Terzah Horton, Cloos, Jacqueline
Individual immunoproteasome subunit protein expression in relapsed childhood acute leukaemia patients. Figure S2. Proteasome subunit mRNA expression in NBM cells. Figure S3. Proteasome subunit catalytic activity in relapsed childhood ALL and AML pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ebae9dc88efcf710e3d24ef12432464e